Sanofi Adr Stock Analysis

Sanofi Stock Analysis Notes

The company has price-to-book ratio of 1.44. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sanofi ADR has Price/Earnings To Growth (PEG) ratio of 0.84. The entity last dividend was issued on the 9th of May 2024. The firm had 5:1 split on the 30th of September 2013. Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. Sanofi was founded in 1973 and is headquartered in Paris, France. Sanofi-Aventis operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. It employs 95442 people. To find out more about Sanofi ADR contact Serge Weinberg at 33 1 53 77 40 00 or learn more at https://www.sanofi.com.

Sanofi ADR Investment Alerts

Sanofi ADR Upcoming and Recent Events

Sanofi Largest EPS Surprises

View All Earnings Estimates

Sanofi ADR Thematic Classifications

Sanofi Stock Institutional Investors

Note, although Sanofi ADR's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Sanofi Market Capitalization

The company currently falls under 'Mega-Cap' category with a total capitalization of 113.46 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sanofi ADR's market, we take the total number of its shares issued and multiply it by Sanofi ADR's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Sanofi Profitablity

The company has Net Profit Margin of 0.12 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.07 %, which entails that for every 100 dollars of revenue, it generated $0.07 of operating income.

Management Efficiency

Sanofi ADR has Return on Asset of 0.0454 % which means that on every $100 spent on assets, it made $0.0454 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0727 %, implying that it generated $0.0727 on every 100 dollars invested. Sanofi ADR's management efficiency ratios could be used to measure how well Sanofi ADR manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to 0.14 in 2024. Return On Capital Employed is likely to rise to 0.17 in 2024. At this time, Sanofi ADR's Non Currrent Assets Other are fairly stable compared to the past year. Intangible Assets is likely to rise to about 77.3 B in 2024, whereas Total Assets are likely to drop slightly above 88.2 B in 2024.

Technical Drivers

As of the 19th of April, Sanofi ADR has the Variance of 1.1, coefficient of variation of (560.16), and Risk Adjusted Performance of (0.11). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sanofi ADR, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate thirteen technical drivers for Sanofi ADR, which can be compared to its competition. Please validate Sanofi ADR market risk adjusted performance and treynor ratio to decide if Sanofi ADR is priced more or less accurately, providing market reflects its prevalent price of 45.39 per share. Given that Sanofi ADR has information ratio of (0.24), we advise you to double-check Sanofi ADR's current market performance to make sure the company can sustain itself at a future point.

Sanofi ADR Price Movement Analysis

Sanofi ADR Predictive Daily Indicators

Sanofi ADR Corporate Filings

Sanofi ADR Forecast Models

Sanofi ADR's time-series forecasting models are one of many Sanofi ADR's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Sanofi ADR's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Sanofi ADR prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Sanofi shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Sanofi ADR. By using and applying Sanofi Stock analysis, traders can create a robust methodology for identifying Sanofi entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Sanofi analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Sanofi analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Sanofi ADR stock analysis indicators help investors evaluate how Sanofi ADR stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Sanofi ADR shares will generate the highest return on investment. By understating and applying Sanofi ADR stock analysis, traders can identify Sanofi ADR position entry and exit signals to maximize returns.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanofi ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.

Is Sanofi ADR's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sanofi ADR. If investors know Sanofi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sanofi ADR listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Sanofi ADR is measured differently than its book value, which is the value of Sanofi that is recorded on the company's balance sheet. Investors also form their own opinion of Sanofi ADR's value that differs from its market value or its book value, called intrinsic value, which is Sanofi ADR's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sanofi ADR's market value can be influenced by many factors that don't directly affect Sanofi ADR's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Sanofi ADR's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanofi ADR is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sanofi ADR's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.